Nov 12, 2020

Osborne Clarke advised myo on the deal. The Munich-based BonVenture Group is investing a seven-figure amount in the digital health start-up myo with its high-impact fund “BonVenture III”. This is the second major round of funding for the digital health company founded in 2017. The existing shareholders, the nursing home operators Agaplesion and Carpe Diem as well as the venture capital funds Axel Springer Plug & Play, Think Health, Mountain Partners and Round Hill Ventures are also investing a further seven-digit amount in this round. myo offers the first Software-as-a-Service (SaaS) solution for direct digital communication between carers, relatives and the ecosystem of service providers in nursing homes. The app enables the intuitive exchange of photos, videos, voice messages and video telephony, which has been in great demand since the beginning of the Covid-19 crisis. According to its own statements, myo already connects people in over 120 institutions and in 3 countries with its multilingual SaaS solution. The company has also managed to enter into collaborations with industry giants such as the full-service linen supplier CWS. The next growth phase begins with the investment. The Osborne Clarke team led by Till-Manuel Saur (Picture – Corporate / Venture Capital) consisted of Nicolas Gabrysch and Philipp Niedermeyer (both Corporate / Venture Capital).